Prediction of postpartum HELLP syndrome, postpartum eclampsia, or preeclampsia postpartum

A method for predicting the risk for a female subject, to develop at least an adverse consequence which be related to preeclampsia, after giving birth to a child, which process comprises the steps of: ) measured in a first sample obtained from a female subject with a pregnancy uneventful, before giving birth to the child, (i) the level of the biomarker sFlt-1 (tyrosine kinase fms-like type 1, soluble) or the level of the biomarker Endoglin, and (ii) the level biomarcardor PIGF (placental growth factor), b) calculating the first ratio factor biomarker levels, as measured in step a), c ) measuring in a second sample obtained from said female subject, after giving birth to a child, the biomarker levels measured in step a), d) calculating the second factor ratio of the levels measured in step c), e) comparing the segund or factor in relation to the first factor relationship.